Inmaculada de Melo-Martín
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Inmaculada de Melo-Martín has a total of 174 co-authors. Here are the top co-authors by number of shared publications:
- Kristen Intemann
Montana State University
20 shared publications Kristen Intemann
6 shared publicationsIna N. Cholst
C The Ronald O. Perelman and Claudia Cohen Center for Reproductive Medicine , Weill Cornell Medical College
3 shared publications- Joseph J. Fins
Weill Cornell Medical College
3 shared publications - Nicole Meredyth
New York-Presbyterian Hospital/Weill Cornell Medical Center
3 shared publications - Ronald G. Crystal
Department of Genetic Medicine, Weill Cornell Medicine, New York, New York, USA
3 shared publications
Latest Publications
- Open Access
- 18 August 2026
- Published by American Society for Microbiology in Journal of Virology
- Vol. 100 (8) , e0042026
Future-use consent and human virome research: ethical challenges
Future-use consent frameworks enable broad research on biospecimens and now extend to human virome studies. However, virome research challenges the core assumptions underlying these consent models. We examine four dimensions of concern: evolving interpretive frameworks for biospecimens, the unforeseen sensitivity of viral findings, unanticipated downstream uses of samples, and unresolved questions regarding the return of results. These features call for updated governance capable of sustaining the ethical legitimacy of clinical research in rapidly evolving scientific landscapes.
- 18 August 2026
- Published by American Society for Microbiology in Journal of Virology
- Vol. 100 (8) , e0042026
Open AccessFuture-use consent and human virome research: ethical challenges
Future-use consent frameworks enable broad research on biospecimens and now extend to human virome studies. However, virome research challenges the core assumptions underlying these consent models. We examine four dimensions of concern: evolving interpretive frameworks for biospecimens, the unforeseen sensitivity of viral findings, unanticipated downstream uses of samples, and unresolved questions regarding the return of results. These features call for updated governance capable of sustaining the ethical legitimacy of clinical research in rapidly evolving scientific landscapes.
- 10 March 2026
- Published by Taylor & Francis
- p. 209-219
Fda Evidentiary Standards and the Need to Attend to Stakeholders' Values
Although it seems both ethically and epistemically appropriate to engage with publics to ensure that values used in research consider the interests of relevant stakeholders, doing so successfully faces serious challenges. Because values play central roles in drug and medical device research, using the US Food and Drug Administration's (FDA) attempts to incorporate stakeholders’ values can offer insights into these problems. I point out challenges regarding the incorporation of what are arguably legitimate but conflicting values from relevant stakeholders. Identifying these challenges is necessary to determine what strategies might be more likely to address them. Readers may be interested in these Handbook chapters as well: Karen Kovaka, “Measuring the Public's Values: Are the Data Adequate for Purpose?”; S. Andrew Schroeder, “Scientific Knowledge as a Public Resource: Arguments and Challenges for a Democratic Approach to Values in Science.”
- 10 March 2026
- Published by Taylor & Francis
- p. 209-219
Fda Evidentiary Standards and the Need to Attend to Stakeholders' Values
Although it seems both ethically and epistemically appropriate to engage with publics to ensure that values used in research consider the interests of relevant stakeholders, doing so successfully faces serious challenges. Because values play central roles in drug and medical device research, using the US Food and Drug Administration's (FDA) attempts to incorporate stakeholders’ values can offer insights into these problems. I point out challenges regarding the incorporation of what are arguably legitimate but conflicting values from relevant stakeholders. Identifying these challenges is necessary to determine what strategies might be more likely to address them. Readers may be interested in these Handbook chapters as well: Karen Kovaka, “Measuring the Public's Values: Are the Data Adequate for Purpose?”; S. Andrew Schroeder, “Scientific Knowledge as a Public Resource: Arguments and Challenges for a Democratic Approach to Values in Science.”
- 17 December 2025
- Published by Springer Nature in Synthese
- Vol. 207 (1)
Public engagement with science: tempering our expectations
- 17 December 2025
- Published by Springer Nature in Synthese
- Vol. 207 (1)
Public engagement with science: tempering our expectations
- 29 May 2025
- Published by Taylor & Francis in Accountability in Research
- Vol. 33 (3) , 1-21
Research integrity in Spain: Great expectations, mediocre results
Reliable scientific knowledge allows us to better understand the natural world, grounds interventions to improve health and wellbeing of humans and other entities, contributes to economic development, and informs policymaking. Ensuring the integrity of scientific research is necessary to advance these various benefits and to safeguard the public's warranted trust in science. Although a variety of complex factors are likely to play a role in advancing or hindering research integrity, some evidence shows that institutional and national policies can be more or less conducive to promoting research integrity and preventing misconduct. I focus here on Spain. I critically assess Spanish legislation and institutional policies and argue that while they proclaim ethical values consistent with fostering research integrity and preventing misconduct, these values fail to be put into practice. I explain some factors that contribute to these failings, and I also offer some suggestions that could contribute to ensuring the respect of ethical values already enshrined in Spanish policies.
- 29 May 2025
- Published by Taylor & Francis in Accountability in Research
- Vol. 33 (3) , 1-21
Research integrity in Spain: Great expectations, mediocre results
Reliable scientific knowledge allows us to better understand the natural world, grounds interventions to improve health and wellbeing of humans and other entities, contributes to economic development, and informs policymaking. Ensuring the integrity of scientific research is necessary to advance these various benefits and to safeguard the public's warranted trust in science. Although a variety of complex factors are likely to play a role in advancing or hindering research integrity, some evidence shows that institutional and national policies can be more or less conducive to promoting research integrity and preventing misconduct. I focus here on Spain. I critically assess Spanish legislation and institutional policies and argue that while they proclaim ethical values consistent with fostering research integrity and preventing misconduct, these values fail to be put into practice. I explain some factors that contribute to these failings, and I also offer some suggestions that could contribute to ensuring the respect of ethical values already enshrined in Spanish policies.
- 15 April 2025
- Published by Springer Nature in Asian Journal of Philosophy
- Vol. 4 (1) , 1-7
Selective uptake: What is the challenge about?
- 15 April 2025
- Published by Springer Nature in Asian Journal of Philosophy
- Vol. 4 (1) , 1-7
Selective uptake: What is the challenge about?
- 2 August 2024
- Published by Taylor & Francis in The American Journal of Bioethics
- Vol. 24 (8) , 27-29
Gene Editing, Genetic Selection, and Reasons That Matter
- 2 August 2024
- Published by Taylor & Francis in The American Journal of Bioethics
- Vol. 24 (8) , 27-29
Gene Editing, Genetic Selection, and Reasons That Matter
- 25 June 2024
- Published by SAGE Publications in Biopreservation and Biobanking
- Vol. 22 (3) , 242-247
Biobanking Legislation in Spain: Advancing or Undermining Its Ethical Values?
Biobanks are important resources for improving public health and individual care. Some legal frameworks can be more or less conducive to advancing the potential benefits of biobanks. The purpose of this article is to assess biobanking legislation and practices in Spain to determine how well they fare in such a regard. We focus here on some of the primary ethical values that ground relevant legislation and that we believe are consistent with promoting biobanking benefits: the value of scientific research; efficient use of scarce resources; and respect for the dignity of donors. We argue that although Spanish regulations advance these values in important ways, they also have provisions that undermine them and thus risk limiting the potential benefits of biobanks. We offer some suggestions for improvement.
- 25 June 2024
- Published by SAGE Publications in Biopreservation and Biobanking
- Vol. 22 (3) , 242-247
Biobanking Legislation in Spain: Advancing or Undermining Its Ethical Values?
Biobanks are important resources for improving public health and individual care. Some legal frameworks can be more or less conducive to advancing the potential benefits of biobanks. The purpose of this article is to assess biobanking legislation and practices in Spain to determine how well they fare in such a regard. We focus here on some of the primary ethical values that ground relevant legislation and that we believe are consistent with promoting biobanking benefits: the value of scientific research; efficient use of scarce resources; and respect for the dignity of donors. We argue that although Spanish regulations advance these values in important ways, they also have provisions that undermine them and thus risk limiting the potential benefits of biobanks. We offer some suggestions for improvement.
- Open Access
- 3 June 2024
- Published by Cambridge University Press (CUP) in Philosophy of Science
- Vol. 91 (4) , 851-868
Concerns about Contextual Values in Science and the Legitimate/Illegitimate Distinction
Philosophers of science have come to accept that contextual values can play unavoidable and desirable roles in science. This has raised concerns about the need to distinguish legitimate and illegitimate value influences in scientific inquiry. I discuss here four such concerns: epistemic distortion, value imposition, undermining of public trust in science, and the use of objectionable values. I contend that preserving epistemic integrity and avoiding value imposition provide good reasons to attempt to distinguish between legitimate and illegitimate influences of values in science. However, the trust and the objectionable values concerns constitute no good reason for demarcation criteria.
- 3 June 2024
- Published by Cambridge University Press (CUP) in Philosophy of Science
- Vol. 91 (4) , 851-868
Open AccessConcerns about Contextual Values in Science and the Legitimate/Illegitimate Distinction
Philosophers of science have come to accept that contextual values can play unavoidable and desirable roles in science. This has raised concerns about the need to distinguish legitimate and illegitimate value influences in scientific inquiry. I discuss here four such concerns: epistemic distortion, value imposition, undermining of public trust in science, and the use of objectionable values. I contend that preserving epistemic integrity and avoiding value imposition provide good reasons to attempt to distinguish between legitimate and illegitimate influences of values in science. However, the trust and the objectionable values concerns constitute no good reason for demarcation criteria.
- 6 November 2023
- Published by Springer Nature in Metascience
- Vol. 33 (1) , 5-10
Just the facts ma'am: some concerns about the identification of future-proof science
- 6 November 2023
- Published by Springer Nature in Metascience
- Vol. 33 (1) , 5-10
Just the facts ma'am: some concerns about the identification of future-proof science
- 6 September 2023
- Published by Springer Nature in Synthese
- Vol. 202 (3) , 1-17
On masks and masking: epistemic harms and science communication
- 6 September 2023
- Published by Springer Nature in Synthese
- Vol. 202 (3) , 1-17
On masks and masking: epistemic harms and science communication